Rx (Prescription Medicine)
USD $ 16.00
Mapstabine 500mg Tablet 是一种含有甲氨蝶呤（Methotrexate）活性成分的处方药。甲氨蝶呤是一种化疗药物和免疫抑制剂，通过干扰体内某些细胞的生长，尤其针对快速分裂的细胞。它用于治疗多种病症，包括白血病、淋巴瘤和乳腺癌等某些类型的癌症。此外，它还被用于治疗类风湿性关节炎和银屑病等自身免疫性疾病，通过抑制免疫系统的过度活性来减轻炎症并减缓疾病进展。
Mapstabine 500mg Tablet 的典型用法和剂量由医疗专业人员根据具体病情、病情严重程度以及患者个体反应来确定。通常口服并配以一杯全水服用。患者应严格遵循医生的指示，按规定的剂量和频率服用。常见的不良反应可能包括恶心、呕吐、腹泻、口腔溃疡、脱发、疲劳以及对感染的易感性增加。严重的不良反应也可能发生，如出现任何异常症状，患者应立即向医生报告。Mapstabine 500mg Tablet 应储存在室温、避光防潮的环境中，并放在儿童不易触及的地方。
| Brand Name | |
|---|---|
| Molecule | |
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type |
其他品牌的 Capecitabine 500 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
